fanta.bio Sample: CNhs10877
16987 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1132 / 13198 (8.6%) | 363 / 131980 (0.3%) | −324.0 | −324.0 | 31.18 |
| HIF1A SRX11007095 | HK-2 Kidney | 2218 / 13198 (16.8%) | 773 / 131980 (0.6%) | −324.0 | −324.0 | 28.69 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1645 / 13198 (12.5%) | 608 / 131980 (0.5%) | −324.0 | −324.0 | 27.06 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1606 / 13198 (12.2%) | 650 / 131980 (0.5%) | −324.0 | −324.0 | 24.71 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2150 / 13198 (16.3%) | 963 / 131980 (0.7%) | −324.0 | −324.0 | 22.33 |
| TP53 SRX19538279 | Osteoblasts Bone | 511 / 13198 (3.9%) | 231 / 131980 (0.2%) | −324.0 | −324.0 | 22.12 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2223 / 13198 (16.8%) | 1008 / 131980 (0.8%) | −324.0 | −324.0 | 22.05 |
| SCML2 SRX644728 | 293 Kidney | 1357 / 13198 (10.3%) | 657 / 131980 (0.5%) | −324.0 | −324.0 | 20.65 |
| FOXP1 SRX736067 | LNCAP Prostate | 1668 / 13198 (12.6%) | 1027 / 131980 (0.8%) | −324.0 | −324.0 | 16.24 |
| MYH11 SRX265221 | ME-1 Blood | 777 / 13198 (5.9%) | 508 / 131980 (0.4%) | −324.0 | −324.0 | 15.30 |
| BRD4 SRX9419935 | BT-474 Breast | 3227 / 13198 (24.5%) | 2322 / 131980 (1.8%) | −324.0 | −324.0 | 13.90 |
| MED1 SRX9419945 | BT-474 Breast | 3184 / 13198 (24.1%) | 2323 / 131980 (1.8%) | −324.0 | −324.0 | 13.71 |
| MED1 SRX9419944 | BT-474 Breast | 3136 / 13198 (23.8%) | 2291 / 131980 (1.7%) | −324.0 | −324.0 | 13.69 |
| BRD4 SRX9419937 | BT-474 Breast | 3190 / 13198 (24.2%) | 2341 / 131980 (1.8%) | −324.0 | −324.0 | 13.63 |
| MED1 SRX9419946 | BT-474 Breast | 3260 / 13198 (24.7%) | 2436 / 131980 (1.8%) | −324.0 | −324.0 | 13.38 |
| BRD4 SRX9419938 | BT-474 Breast | 3213 / 13198 (24.3%) | 2424 / 131980 (1.8%) | −324.0 | −324.0 | 13.26 |
| BRD4 SRX9419936 | BT-474 Breast | 3245 / 13198 (24.6%) | 2453 / 131980 (1.9%) | −324.0 | −324.0 | 13.23 |
| MED1 SRX9419947 | BT-474 Breast | 3114 / 13198 (23.6%) | 2380 / 131980 (1.8%) | −324.0 | −324.0 | 13.08 |
| EZH2 SRX2146136 | LNCAP Prostate | 6851 / 13198 (51.9%) | 6681 / 131980 (5.1%) | −324.0 | −324.0 | 10.25 |
| BRD4 SRX736201 | 90-8TL Neural | 5223 / 13198 (39.6%) | 5415 / 131980 (4.1%) | −324.0 | −324.0 | 9.65 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 683 / 13198 (5.2%) | 711 / 131980 (0.5%) | −324.0 | −324.0 | 9.61 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1582 / 13198 (12.0%) | 2202 / 131980 (1.7%) | −324.0 | −324.0 | 7.18 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1309 / 13198 (9.9%) | 2926 / 131980 (2.2%) | −324.0 | −324.0 | 4.47 |
| PBX4 SRX2731658 | PC-3 Prostate | 615 / 13198 (4.7%) | 20646 / 131980 (15.6%) | −322.5 | −319.4 | 0.30 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1433 / 13198 (10.9%) | 4009 / 131980 (3.0%) | −314.4 | −311.3 | 3.57 |
| HIF1A SRX20663235 | HK-2 Kidney | 465 / 13198 (3.5%) | 223 / 131980 (0.2%) | −309.7 | −306.6 | 20.85 |
| TP53 SRX19538274 | U2OS Bone | 419 / 13198 (3.2%) | 146 / 131980 (0.1%) | −306.1 | −303.0 | 28.70 |
| TP53 SRX19538268 | U2OS Bone | 410 / 13198 (3.1%) | 150 / 131980 (0.1%) | −295.6 | −292.5 | 27.33 |
| TP53 SRX19538276 | U2OS Bone | 409 / 13198 (3.1%) | 157 / 131980 (0.1%) | −291.0 | −288.0 | 26.05 |
| AGO2 SRX4708039 | Hep G2 Liver | 1704 / 13198 (12.9%) | 5815 / 131980 (4.4%) | −289.7 | −286.7 | 2.93 |
| TP53 SRX19538280 | Osteoblasts Bone | 407 / 13198 (3.1%) | 174 / 131980 (0.1%) | −280.7 | −277.7 | 23.39 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 619 / 13198 (4.7%) | 743 / 131980 (0.6%) | −274.0 | −270.9 | 8.33 |
| TP53 SRX19538273 | U2OS Bone | 372 / 13198 (2.8%) | 126 / 131980 (0.1%) | −273.6 | −270.6 | 29.52 |
| FOS SRX150477 | MCF 10A Breast | 390 / 13198 (3.0%) | 15358 / 131980 (11.6%) | −271.0 | −268.0 | 0.25 |
| FOS SRX150478 | MCF 10A Breast | 417 / 13198 (3.2%) | 15750 / 131980 (11.9%) | −268.4 | −265.4 | 0.26 |
| TP53 SRX19538267 | U2OS Bone | 372 / 13198 (2.8%) | 137 / 131980 (0.1%) | −267.6 | −264.7 | 27.15 |
| TP53 SRX19538275 | U2OS Bone | 373 / 13198 (2.8%) | 140 / 131980 (0.1%) | −267.0 | −264.0 | 26.64 |
| TP53 SRX19538281 | Osteoblasts Bone | 427 / 13198 (3.2%) | 246 / 131980 (0.2%) | −266.9 | −263.9 | 17.36 |
| YAP1 SRX757325 | H2052 Lung | 446 / 13198 (3.4%) | 16011 / 131980 (12.1%) | −260.5 | −257.6 | 0.28 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 613 / 13198 (4.6%) | 800 / 131980 (0.6%) | −257.5 | −254.5 | 7.66 |
| TP53 SRX19538269 | U2OS Bone | 454 / 13198 (3.4%) | 335 / 131980 (0.3%) | −257.2 | −254.3 | 13.55 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 381 / 13198 (2.9%) | 183 / 131980 (0.1%) | −253.4 | −250.5 | 20.82 |
| KAT6A SRX20971022 | Fibroblasts Others | 297 / 13198 (2.3%) | 50 / 131980 (0.0%) | −251.7 | −248.8 | 59.40 |
| RUNX1 SRX2513054 | 293 Kidney | 2803 / 13198 (21.2%) | 13893 / 131980 (10.5%) | −249.5 | −246.6 | 2.02 |
| YAP1 SRX757326 | H2052 Lung | 372 / 13198 (2.8%) | 14330 / 131980 (10.9%) | −246.6 | −243.8 | 0.26 |
| IRF3 SRX11453858 | Hep G2 Liver | 304 / 13198 (2.3%) | 70 / 131980 (0.1%) | −243.8 | −240.9 | 43.43 |
| TP53 SRX19538270 | U2OS Bone | 429 / 13198 (3.3%) | 329 / 131980 (0.2%) | −238.9 | −236.1 | 13.04 |
| 5-mC SRX882970 | LNCAP Prostate | 2492 / 13198 (18.9%) | 11985 / 131980 (9.1%) | −234.0 | −231.2 | 2.08 |
| FOS SRX4192880 | MCF 10A Breast | 291 / 13198 (2.2%) | 12504 / 131980 (9.5%) | −233.5 | −230.7 | 0.23 |
| 5-mC SRX882968 | LNCAP Prostate | 2471 / 13198 (18.7%) | 11896 / 131980 (9.0%) | −231.3 | −228.5 | 2.08 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1836 / 13198 (13.9%) | 7542 / 131980 (5.7%) | −231.1 | −228.2 | 2.43 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 439 / 13198 (3.3%) | 14567 / 131980 (11.0%) | −217.2 | −214.4 | 0.30 |
| IRF3 SRX11453861 | Hep G2 Liver | 271 / 13198 (2.1%) | 67 / 131980 (0.1%) | −214.2 | −211.4 | 40.45 |
| 5-mC SRX882965 | LNCAP Prostate | 2029 / 13198 (15.4%) | 9178 / 131980 (7.0%) | −212.9 | −210.1 | 2.21 |
| TP53 SRX19538282 | Osteoblasts Bone | 365 / 13198 (2.8%) | 252 / 131980 (0.2%) | −212.5 | −209.7 | 14.48 |
| TP53 SRX19538271 | U2OS Bone | 587 / 13198 (4.4%) | 952 / 131980 (0.7%) | −211.7 | −208.9 | 6.17 |
| FOXA1 SRX4815198 | MCF-7 Breast | 728 / 13198 (5.5%) | 18836 / 131980 (14.3%) | −210.9 | −208.1 | 0.39 |
| BRD4 SRX736204 | 90-8TL Neural | 861 / 13198 (6.5%) | 2218 / 131980 (1.7%) | −204.0 | −201.2 | 3.88 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 458 / 13198 (3.5%) | 545 / 131980 (0.4%) | −203.2 | −200.5 | 8.40 |
| FOXA1 SRX176862 | MCF-7 Breast | 250 / 13198 (1.9%) | 10799 / 131980 (8.2%) | −200.9 | −198.1 | 0.23 |
| AR SRX10820653 | LNCAP Prostate | 306 / 13198 (2.3%) | 155 / 131980 (0.1%) | −199.9 | −197.2 | 19.74 |
| FOS SRX150476 | MCF 10A Breast | 355 / 13198 (2.7%) | 12618 / 131980 (9.6%) | −199.6 | −196.8 | 0.28 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1222 / 13198 (9.3%) | 4243 / 131980 (3.2%) | −198.6 | −195.9 | 2.88 |
| FOXA1 SRX4815197 | MCF-7 Breast | 526 / 13198 (4.0%) | 15363 / 131980 (11.6%) | −198.5 | −195.8 | 0.34 |
| FOS SRX150517 | MCF 10A Breast | 351 / 13198 (2.7%) | 12504 / 131980 (9.5%) | −198.2 | −195.5 | 0.28 |
| CIC SRX13262055 | Astrocytes Neural | 2522 / 13198 (19.1%) | 13092 / 131980 (9.9%) | −196.7 | −194.0 | 1.93 |
| ESR1 SRX371478 | MCF-7 Breast | 258 / 13198 (2.0%) | 10786 / 131980 (8.2%) | −195.5 | −192.8 | 0.24 |
| AGO2 SRX6783957 | Hep G2 Liver | 1080 / 13198 (8.2%) | 3477 / 131980 (2.6%) | −195.0 | −192.3 | 3.11 |
| Epitope tags SRX10549776 | K-562 Blood | 1187 / 13198 (9.0%) | 4092 / 131980 (3.1%) | −194.7 | −192.0 | 2.90 |
| FOXA1 SRX176863 | MCF-7 Breast | 237 / 13198 (1.8%) | 10287 / 131980 (7.8%) | −191.6 | −188.9 | 0.23 |
| AR SRX1067071 | LHSAR Prostate | 426 / 13198 (3.2%) | 13476 / 131980 (10.2%) | −189.5 | −186.8 | 0.32 |
| AGO2 SRX6783958 | Hep G2 Liver | 1055 / 13198 (8.0%) | 3418 / 131980 (2.6%) | −188.6 | −186.0 | 3.09 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 746 / 13198 (5.7%) | 1808 / 131980 (1.4%) | −188.3 | −185.7 | 4.13 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1489 / 13198 (11.3%) | 6049 / 131980 (4.6%) | −188.3 | −185.6 | 2.46 |
| ESR1 SRX7624157 | MCF-7 Breast | 596 / 13198 (4.5%) | 16078 / 131980 (12.2%) | −188.0 | −185.4 | 0.37 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 792 / 13198 (6.0%) | 18952 / 131980 (14.4%) | −187.9 | −185.3 | 0.42 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 233 / 13198 (1.8%) | 10037 / 131980 (7.6%) | −185.6 | −183.0 | 0.23 |
| GATA3 SRX190239 | MCF-7 Breast | 315 / 13198 (2.4%) | 11490 / 131980 (8.7%) | −185.3 | −182.7 | 0.27 |
| ESR1 SRX371469 | MCF-7 Breast | 211 / 13198 (1.6%) | 9575 / 131980 (7.3%) | −183.9 | −181.2 | 0.22 |
| BRD1 SRX286203 | RKO Digestive tract | 1011 / 13198 (7.7%) | 3257 / 131980 (2.5%) | −181.9 | −179.3 | 3.10 |
| JUNB SRX8488088 | SUM 229PE Breast | 437 / 13198 (3.3%) | 13389 / 131980 (10.1%) | −181.4 | −178.8 | 0.33 |
| FOXA1 SRX1161177 | MCF-7 Breast | 201 / 13198 (1.5%) | 9306 / 131980 (7.1%) | −181.1 | −178.5 | 0.22 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 244 / 13198 (1.8%) | 10081 / 131980 (7.6%) | −180.2 | −177.6 | 0.24 |
| ESR1 SRX4367193 | MCF-7 Breast | 779 / 13198 (5.9%) | 18468 / 131980 (14.0%) | −179.8 | −177.3 | 0.42 |
| KAT7 SRX101303 | RKO Digestive tract | 1134 / 13198 (8.6%) | 4002 / 131980 (3.0%) | −179.2 | −176.6 | 2.83 |
| ESR1 SRX20282961 | MCF-7 Breast | 274 / 13198 (2.1%) | 10580 / 131980 (8.0%) | −178.9 | −176.3 | 0.26 |
| FOXA1 SRX371482 | MCF-7 Breast | 320 / 13198 (2.4%) | 11372 / 131980 (8.6%) | −178.7 | −176.1 | 0.28 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 990 / 13198 (7.5%) | 3184 / 131980 (2.4%) | −178.4 | −175.9 | 3.11 |
| FOS SRX4192879 | MCF 10A Breast | 237 / 13198 (1.8%) | 9848 / 131980 (7.5%) | −176.8 | −174.2 | 0.24 |
| TLE3 SRX4815191 | MCF-7 Breast | 197 / 13198 (1.5%) | 9097 / 131980 (6.9%) | −176.6 | −174.0 | 0.22 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 271 / 13198 (2.1%) | 10399 / 131980 (7.9%) | −174.8 | −172.3 | 0.26 |
| AR SRX1067070 | LHSAR Prostate | 586 / 13198 (4.4%) | 15466 / 131980 (11.7%) | −174.7 | −172.1 | 0.38 |
| SREBF2 SRX5359048 | HCC70 Breast | 1433 / 13198 (10.9%) | 5936 / 131980 (4.5%) | −174.3 | −171.8 | 2.41 |
| ESR1 SRX371479 | MCF-7 Breast | 189 / 13198 (1.4%) | 8879 / 131980 (6.7%) | −174.3 | −171.7 | 0.21 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 815 / 13198 (6.2%) | 18761 / 131980 (14.2%) | −174.0 | −171.5 | 0.43 |
| FOXA1 SRX371481 | MCF-7 Breast | 232 / 13198 (1.8%) | 9668 / 131980 (7.3%) | −173.7 | −171.2 | 0.24 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 553 / 13198 (4.2%) | 1065 / 131980 (0.8%) | −173.3 | −170.8 | 5.19 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 249 / 13198 (1.9%) | 104 / 131980 (0.1%) | −172.8 | −170.3 | 23.94 |
| ESR1 SRX7624156 | MCF-7 Breast | 372 / 13198 (2.8%) | 12042 / 131980 (9.1%) | −172.4 | −169.9 | 0.31 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 393 / 13198 (3.0%) | 12381 / 131980 (9.4%) | −172.2 | −169.7 | 0.32 |
| FOXA1 SRX3931044 | MCF-7 Breast | 502 / 13198 (3.8%) | 14089 / 131980 (10.7%) | −171.8 | −169.3 | 0.36 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1588 / 13198 (12.0%) | 7036 / 131980 (5.3%) | −170.4 | −167.9 | 2.26 |
| BRPF3 SRX796085 | RKO Digestive tract | 904 / 13198 (6.8%) | 2822 / 131980 (2.1%) | −169.3 | −166.8 | 3.20 |
| SMARCA2 SRX8119677 | MeT-5A Others | 379 / 13198 (2.9%) | 12035 / 131980 (9.1%) | −168.7 | −166.2 | 0.31 |
| AR SRX10820651 | LNCAP Prostate | 306 / 13198 (2.3%) | 240 / 131980 (0.2%) | −168.6 | −166.1 | 12.75 |
| FOXA1 SRX371483 | MCF-7 Breast | 258 / 13198 (2.0%) | 9945 / 131980 (7.5%) | −167.4 | −164.9 | 0.26 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 526 / 13198 (4.0%) | 14303 / 131980 (10.8%) | −167.3 | −164.8 | 0.37 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 576 / 13198 (4.4%) | 15054 / 131980 (11.4%) | −167.2 | −164.7 | 0.38 |
| ESR1 SRX176860 | MCF-7 Breast | 396 / 13198 (3.0%) | 12253 / 131980 (9.3%) | −166.9 | −164.4 | 0.32 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 153 / 13198 (1.2%) | 7958 / 131980 (6.0%) | −166.6 | −164.1 | 0.19 |
| TP53 SRX396254 | Fibroblasts Others | 766 / 13198 (5.8%) | 2121 / 131980 (1.6%) | −166.5 | −164.0 | 3.61 |
| BRPF3 SRX796084 | RKO Digestive tract | 1234 / 13198 (9.3%) | 4817 / 131980 (3.6%) | −165.9 | −163.4 | 2.56 |
| FOXA1 SRX1161176 | MCF-7 Breast | 209 / 13198 (1.6%) | 8997 / 131980 (6.8%) | −165.4 | −163.0 | 0.23 |
| TRP47 SRX4548329 | THP-1 Blood | 2130 / 13198 (16.1%) | 11010 / 131980 (8.3%) | −164.5 | −162.0 | 1.93 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 345 / 13198 (2.6%) | 11309 / 131980 (8.6%) | −163.6 | −161.1 | 0.31 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1509 / 13198 (11.4%) | 6647 / 131980 (5.0%) | −163.3 | −160.9 | 2.27 |
| FOXA1 SRX1161173 | MCF-7 Breast | 166 / 13198 (1.3%) | 8117 / 131980 (6.2%) | −163.3 | −160.8 | 0.20 |
| GATA3 SRX190194 | SK-N-SH Neural | 584 / 13198 (4.4%) | 15017 / 131980 (11.4%) | −162.8 | −160.3 | 0.39 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 339 / 13198 (2.6%) | 11166 / 131980 (8.5%) | −162.2 | −159.8 | 0.30 |
| JUN SRX17561461 | LPS141 Adipocyte | 342 / 13198 (2.6%) | 11209 / 131980 (8.5%) | −162.0 | −159.6 | 0.31 |
| ESR1 SRX371471 | ZR-75-1 Breast | 258 / 13198 (2.0%) | 9767 / 131980 (7.4%) | −161.7 | −159.3 | 0.26 |
| ESR1 SRX20282939 | MCF-7 Breast | 271 / 13198 (2.1%) | 9992 / 131980 (7.6%) | −161.6 | −159.1 | 0.27 |
| ESR1 SRX176861 | MCF-7 Breast | 409 / 13198 (3.1%) | 12273 / 131980 (9.3%) | −161.3 | −158.8 | 0.33 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 304 / 13198 (2.3%) | 10550 / 131980 (8.0%) | −161.2 | −158.8 | 0.29 |
| VGLL1 SRX24602130 | BT-20 Breast | 229 / 13198 (1.7%) | 9237 / 131980 (7.0%) | −161.1 | −158.7 | 0.25 |
| JUN SRX4192884 | MCF 10A Breast | 169 / 13198 (1.3%) | 8113 / 131980 (6.1%) | −161.1 | −158.7 | 0.21 |
| BRPF3 SRX796086 | RKO Digestive tract | 1183 / 13198 (9.0%) | 4579 / 131980 (3.5%) | −161.0 | −158.6 | 2.58 |
| RELA SRX2207673 | HUVEC Cardiovascular | 920 / 13198 (7.0%) | 19713 / 131980 (14.9%) | −161.0 | −158.6 | 0.47 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 417 / 13198 (3.2%) | 618 / 131980 (0.5%) | −160.2 | −157.8 | 6.75 |
| ESR1 SRX371470 | ZR-75-1 Breast | 209 / 13198 (1.6%) | 8830 / 131980 (6.7%) | −159.9 | −157.5 | 0.24 |
| ESR1 SRX20282960 | MCF-7 Breast | 274 / 13198 (2.1%) | 9967 / 131980 (7.6%) | −159.0 | −156.6 | 0.27 |
| TP53 SRX19538272 | U2OS Bone | 489 / 13198 (3.7%) | 901 / 131980 (0.7%) | −159.0 | −156.6 | 5.43 |
| SSRP1 SRX3436567 | HT-1080 Bone | 366 / 13198 (2.8%) | 451 / 131980 (0.3%) | −158.8 | −156.5 | 8.12 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1573 / 13198 (11.9%) | 7182 / 131980 (5.4%) | −158.4 | −156.0 | 2.19 |
| YAP1 SRX5718140 | 293 Kidney | 415 / 13198 (3.1%) | 12230 / 131980 (9.3%) | −157.2 | −154.8 | 0.34 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1338 / 13198 (10.1%) | 5640 / 131980 (4.3%) | −156.8 | −154.4 | 2.37 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 529 / 13198 (4.0%) | 13971 / 131980 (10.6%) | −156.6 | −154.2 | 0.38 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 484 / 13198 (3.7%) | 13286 / 131980 (10.1%) | −156.5 | −154.1 | 0.36 |
| FOXA1 SRX1161175 | MCF-7 Breast | 162 / 13198 (1.2%) | 7838 / 131980 (5.9%) | −156.3 | −153.9 | 0.21 |
| GATA3 SRX5057632 | MCF-7 Breast | 136 / 13198 (1.0%) | 7321 / 131980 (5.5%) | −156.2 | −153.8 | 0.19 |
| GATA3 SRX176864 | MCF-7 Breast | 158 / 13198 (1.2%) | 7748 / 131980 (5.9%) | −155.9 | −153.5 | 0.20 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 228 / 13198 (1.7%) | 9057 / 131980 (6.9%) | −155.9 | −153.5 | 0.25 |
| ESR1 SRX1531791 | MCF-7 Breast | 227 / 13198 (1.7%) | 9035 / 131980 (6.8%) | −155.8 | −153.5 | 0.25 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 402 / 13198 (3.0%) | 11961 / 131980 (9.1%) | −155.2 | −152.8 | 0.34 |
| ESR1 SRX194569 | MCF-7 Breast | 254 / 13198 (1.9%) | 9483 / 131980 (7.2%) | −154.7 | −152.3 | 0.27 |
| ESR1 SRX371476 | MCF-7 Breast | 165 / 13198 (1.3%) | 7844 / 131980 (5.9%) | −154.6 | −152.2 | 0.21 |
| ESR1 SRX371467 | MCF-7 Breast | 255 / 13198 (1.9%) | 9489 / 131980 (7.2%) | −154.4 | −152.0 | 0.27 |
| JUNB SRX8488073 | SUM 229PE Breast | 474 / 13198 (3.6%) | 13052 / 131980 (9.9%) | −154.2 | −151.9 | 0.36 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1290 / 13198 (9.8%) | 5378 / 131980 (4.1%) | −154.2 | −151.8 | 2.40 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 584 / 13198 (4.4%) | 1351 / 131980 (1.0%) | −154.1 | −151.8 | 4.32 |
| JUNB SRX4192882 | MCF 10A Breast | 169 / 13198 (1.3%) | 7907 / 131980 (6.0%) | −154.0 | −151.7 | 0.21 |
| ARID1A SRX5089376 | MCF-7 Breast | 195 / 13198 (1.5%) | 8388 / 131980 (6.4%) | −153.7 | −151.4 | 0.23 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 537 / 13198 (4.1%) | 1146 / 131980 (0.9%) | −153.3 | −150.9 | 4.69 |
| ESR1 SRX194572 | MCF-7 Breast | 138 / 13198 (1.0%) | 7273 / 131980 (5.5%) | −153.1 | −150.8 | 0.19 |
| FOXA1 SRX371480 | MCF-7 Breast | 149 / 13198 (1.1%) | 7487 / 131980 (5.7%) | −152.9 | −150.6 | 0.20 |
| CEBPB SRX150632 | HeLa Uterus | 583 / 13198 (4.4%) | 14641 / 131980 (11.1%) | −152.9 | −150.6 | 0.40 |
| ESR1 SRX371468 | MCF-7 Breast | 142 / 13198 (1.1%) | 7304 / 131980 (5.5%) | −151.5 | −149.2 | 0.19 |
| FOXA1 SRX1787653 | MCF-7 Breast | 184 / 13198 (1.4%) | 8112 / 131980 (6.1%) | −151.3 | −149.0 | 0.23 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 219 / 13198 (1.7%) | 8740 / 131980 (6.6%) | −150.9 | −148.5 | 0.25 |
| JUNB SRX10119386 | MCF 10A Breast | 207 / 13198 (1.6%) | 8519 / 131980 (6.5%) | −150.7 | −148.4 | 0.24 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 840 / 13198 (6.4%) | 18207 / 131980 (13.8%) | −150.6 | −148.3 | 0.46 |
| ESR1 SRX20282972 | MCF-7 Breast | 280 / 13198 (2.1%) | 9789 / 131980 (7.4%) | −150.1 | −147.8 | 0.29 |
| SMARCA4 SRX5212366 | Mel270 Others | 332 / 13198 (2.5%) | 10648 / 131980 (8.1%) | −149.8 | −147.5 | 0.31 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 634 / 13198 (4.8%) | 15270 / 131980 (11.6%) | −149.7 | −147.4 | 0.42 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 322 / 13198 (2.4%) | 10476 / 131980 (7.9%) | −149.6 | −147.3 | 0.31 |
| RAC1 SRX10365541 | MCF-7 Breast | 110 / 13198 (0.8%) | 6594 / 131980 (5.0%) | −149.5 | −147.2 | 0.17 |
| RAC1 SRX10365543 | MCF-7 Breast | 110 / 13198 (0.8%) | 6582 / 131980 (5.0%) | −149.0 | −146.7 | 0.17 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 243 / 13198 (1.8%) | 9112 / 131980 (6.9%) | −148.9 | −146.6 | 0.27 |
| JUNB SRX8488089 | SUM 229PE Breast | 242 / 13198 (1.8%) | 9087 / 131980 (6.9%) | −148.9 | −146.6 | 0.27 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1400 / 13198 (10.6%) | 6209 / 131980 (4.7%) | −148.7 | −146.4 | 2.25 |
| RUNX1 SRX2014504 | Jurkat Blood | 1930 / 13198 (14.6%) | 9952 / 131980 (7.5%) | −148.4 | −146.1 | 1.94 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 218 / 13198 (1.7%) | 8630 / 131980 (6.5%) | −147.7 | −145.4 | 0.25 |
| EP300 SRX150579 | HeLa Uterus | 141 / 13198 (1.1%) | 7171 / 131980 (5.4%) | −147.5 | −145.2 | 0.20 |
| LEO1 SRX1873456 | SEM Blood | 1174 / 13198 (8.9%) | 4763 / 131980 (3.6%) | −146.9 | −144.6 | 2.46 |
| ESR1 SRX371477 | MCF-7 Breast | 101 / 13198 (0.8%) | 6324 / 131980 (4.8%) | −146.7 | −144.5 | 0.16 |
| MEAF6 DRX234811 | 293 Kidney | 1343 / 13198 (10.2%) | 5884 / 131980 (4.5%) | −145.8 | −143.5 | 2.28 |
| ESR1 SRX10365535 | MCF-7 Breast | 197 / 13198 (1.5%) | 8185 / 131980 (6.2%) | −145.8 | −143.5 | 0.24 |
| TEAD1 SRX3401272 | MCF-7 Breast | 174 / 13198 (1.3%) | 7756 / 131980 (5.9%) | −145.7 | −143.4 | 0.22 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1035 / 13198 (7.8%) | 20623 / 131980 (15.6%) | −145.4 | −143.2 | 0.50 |
| BMI1 SRX7196721 | SF8628 Neural | 1381 / 13198 (10.5%) | 6151 / 131980 (4.7%) | −145.3 | −143.0 | 2.25 |
| AR SRX1067066 | LHSAR Prostate | 552 / 13198 (4.2%) | 13901 / 131980 (10.5%) | −145.2 | −142.9 | 0.40 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 245 / 13198 (1.9%) | 9021 / 131980 (6.8%) | −145.0 | −142.8 | 0.27 |
| ESR1 SRX10365536 | MCF-7 Breast | 115 / 13198 (0.9%) | 6555 / 131980 (5.0%) | −144.5 | −142.2 | 0.18 |
| BMI1 SRX644729 | 293 Kidney | 222 / 13198 (1.7%) | 114 / 131980 (0.1%) | −144.4 | −142.2 | 19.47 |
| FOXA1 SRX1161174 | MCF-7 Breast | 256 / 13198 (1.9%) | 9194 / 131980 (7.0%) | −144.4 | −142.1 | 0.28 |
| ESR1 SRX20282954 | MCF-7 Breast | 282 / 13198 (2.1%) | 9635 / 131980 (7.3%) | −144.4 | −142.1 | 0.29 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 232 / 13198 (1.8%) | 8765 / 131980 (6.6%) | −144.1 | −141.9 | 0.26 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 168 / 13198 (1.3%) | 7596 / 131980 (5.8%) | −144.0 | −141.8 | 0.22 |
| FOXA1 SRX100454 | T-47D Breast | 331 / 13198 (2.5%) | 10438 / 131980 (7.9%) | −144.0 | −141.8 | 0.32 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 228 / 13198 (1.7%) | 8690 / 131980 (6.6%) | −143.9 | −141.6 | 0.26 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 451 / 13198 (3.4%) | 12326 / 131980 (9.3%) | −143.7 | −141.4 | 0.37 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 626 / 13198 (4.7%) | 14924 / 131980 (11.3%) | −143.6 | −141.4 | 0.42 |
| ESR1 SRX371475 | BT-474 Breast | 104 / 13198 (0.8%) | 6299 / 131980 (4.8%) | −143.5 | −141.3 | 0.17 |
| SMARCA4 SRX5212362 | Mel270 Others | 455 / 13198 (3.4%) | 12375 / 131980 (9.4%) | −143.3 | −141.1 | 0.37 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 512 / 13198 (3.9%) | 13227 / 131980 (10.0%) | −142.9 | −140.7 | 0.39 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 266 / 13198 (2.0%) | 9312 / 131980 (7.1%) | −142.7 | −140.5 | 0.29 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 226 / 13198 (1.7%) | 8607 / 131980 (6.5%) | −142.5 | −140.3 | 0.26 |
| JUN SRX883584 | MDA-MB-231 Breast | 411 / 13198 (3.1%) | 11660 / 131980 (8.8%) | −142.3 | −140.1 | 0.35 |
| MEAF6 DRX300417 | 293 Kidney | 1230 / 13198 (9.3%) | 5211 / 131980 (3.9%) | −142.1 | −139.9 | 2.36 |
| AR SRX1067067 | LHSAR Prostate | 443 / 13198 (3.4%) | 12129 / 131980 (9.2%) | −141.6 | −139.3 | 0.37 |
| ESR1 SRX2943591 | MCF-7 Breast | 166 / 13198 (1.3%) | 7467 / 131980 (5.7%) | −141.0 | −138.8 | 0.22 |
| FOXA1 SRX11222441 | MCF-7 Breast | 182 / 13198 (1.4%) | 7748 / 131980 (5.9%) | −140.5 | −138.2 | 0.23 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 238 / 13198 (1.8%) | 8742 / 131980 (6.6%) | −140.0 | −137.8 | 0.27 |
| STAT5B SRX831881 | CD8+ T cells Blood | 224 / 13198 (1.7%) | 130 / 131980 (0.1%) | −139.6 | −137.4 | 17.23 |
| ING5 SRX286202 | RKO Digestive tract | 1047 / 13198 (7.9%) | 4098 / 131980 (3.1%) | −139.1 | −136.9 | 2.55 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 237 / 13198 (1.8%) | 8683 / 131980 (6.6%) | −138.7 | −136.5 | 0.27 |
| SS18 SRX3468047 | Fibroblasts Others | 688 / 13198 (5.2%) | 15617 / 131980 (11.8%) | −138.6 | −136.4 | 0.44 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 781 / 13198 (5.9%) | 16915 / 131980 (12.8%) | −138.5 | −136.3 | 0.46 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 104 / 13198 (0.8%) | 6159 / 131980 (4.7%) | −138.5 | −136.3 | 0.17 |
| PGR SRX1012655 | MCF-7 Breast | 148 / 13198 (1.1%) | 7049 / 131980 (5.3%) | −138.5 | −136.3 | 0.21 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 198 / 13198 (1.5%) | 7978 / 131980 (6.0%) | −138.3 | −136.1 | 0.25 |
| YAP1 SRX10119364 | MCF 10A Breast | 207 / 13198 (1.6%) | 8131 / 131980 (6.2%) | −138.0 | −135.8 | 0.25 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 727 / 13198 (5.5%) | 2240 / 131980 (1.7%) | −137.8 | −135.7 | 3.25 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1421 / 13198 (10.8%) | 6581 / 131980 (5.0%) | −137.8 | −135.6 | 2.16 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 370 / 13198 (2.8%) | 10849 / 131980 (8.2%) | −137.5 | −135.3 | 0.34 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 373 / 13198 (2.8%) | 10898 / 131980 (8.3%) | −137.5 | −135.3 | 0.34 |
| ARID1A SRX5089379 | MCF-7 Breast | 252 / 13198 (1.9%) | 8903 / 131980 (6.7%) | −137.4 | −135.2 | 0.28 |
| MITF SRX1555436 | 501A Epidermis | 1539 / 13198 (11.7%) | 7416 / 131980 (5.6%) | −137.1 | −134.9 | 2.08 |
| MECOM SRX23677885 | HNT-34 Blood | 1387 / 13198 (10.5%) | 6365 / 131980 (4.8%) | −136.9 | −134.7 | 2.18 |
| JUNB SRX10119383 | MCF 10A Breast | 162 / 13198 (1.2%) | 7269 / 131980 (5.5%) | −136.9 | −134.7 | 0.22 |
| FOS SRX3322636 | MCF-7 Breast | 159 / 13198 (1.2%) | 7203 / 131980 (5.5%) | −136.7 | −134.5 | 0.22 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 237 / 13198 (1.8%) | 8614 / 131980 (6.5%) | −136.5 | −134.4 | 0.28 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1410 / 13198 (10.7%) | 6535 / 131980 (5.0%) | −136.3 | −134.1 | 2.16 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 229 / 13198 (1.7%) | 8469 / 131980 (6.4%) | −136.3 | −134.1 | 0.27 |
| ESR1 SRX4367192 | MCF-7 Breast | 561 / 13198 (4.3%) | 13705 / 131980 (10.4%) | −136.3 | −134.1 | 0.41 |
| JUNB SRX8488074 | SUM 229PE Breast | 356 / 13198 (2.7%) | 10580 / 131980 (8.0%) | −136.2 | −134.0 | 0.34 |
| ESR1 SRX371474 | BT-474 Breast | 101 / 13198 (0.8%) | 6030 / 131980 (4.6%) | −136.1 | −133.9 | 0.17 |
| TLE3 SRX4815192 | MCF-7 Breast | 234 / 13198 (1.8%) | 8549 / 131980 (6.5%) | −136.1 | −133.9 | 0.27 |
| FOXA1 SRX11222437 | MCF-7 Breast | 179 / 13198 (1.4%) | 7560 / 131980 (5.7%) | −136.0 | −133.8 | 0.24 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1641 / 13198 (12.4%) | 8167 / 131980 (6.2%) | −135.9 | −133.8 | 2.01 |
| WWTR1 SRX10119367 | MCF 10A Breast | 307 / 13198 (2.3%) | 9776 / 131980 (7.4%) | −135.9 | −133.7 | 0.31 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 531 / 13198 (4.0%) | 13242 / 131980 (10.0%) | −135.7 | −133.5 | 0.40 |
| SMARCA4 SRX5212357 | Mel270 Others | 390 / 13198 (3.0%) | 11097 / 131980 (8.4%) | −135.6 | −133.4 | 0.35 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 239 / 13198 (1.8%) | 8608 / 131980 (6.5%) | −135.3 | −133.1 | 0.28 |
| AR SRX9469988 | LAPC-4 Prostate | 362 / 13198 (2.7%) | 10641 / 131980 (8.1%) | −135.2 | −133.0 | 0.34 |
| NR3C1 SRX17639412 | A549 Lung | 287 / 13198 (2.2%) | 9424 / 131980 (7.1%) | −135.2 | −133.0 | 0.30 |
| SMARCA4 SRX5212371 | Mel270 Others | 380 / 13198 (2.9%) | 10923 / 131980 (8.3%) | −135.0 | −132.8 | 0.35 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1439 / 13198 (10.9%) | 6767 / 131980 (5.1%) | −134.8 | −132.7 | 2.13 |
| FOXA1 SRX3923514 | MCF-7 Breast | 269 / 13198 (2.0%) | 9106 / 131980 (6.9%) | −134.8 | −132.7 | 0.30 |
| ESR1 SRX10365532 | MCF-7 Breast | 130 / 13198 (1.0%) | 6587 / 131980 (5.0%) | −134.8 | −132.6 | 0.20 |
| ESR1 SRX20282973 | MCF-7 Breast | 327 / 13198 (2.5%) | 10064 / 131980 (7.6%) | −134.8 | −132.6 | 0.32 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 417 / 13198 (3.2%) | 774 / 131980 (0.6%) | −134.6 | −132.5 | 5.39 |
| MECOM SRX23677896 | HNT-34 Blood | 1664 / 13198 (12.6%) | 8370 / 131980 (6.3%) | −134.5 | −132.4 | 1.99 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 226 / 13198 (1.7%) | 8356 / 131980 (6.3%) | −134.4 | −132.2 | 0.27 |
| FOSL2 SRX190296 | SK-N-SH Neural | 361 / 13198 (2.7%) | 10590 / 131980 (8.0%) | −134.1 | −131.9 | 0.34 |
| FOXA1 SRX11222442 | MCF-7 Breast | 164 / 13198 (1.2%) | 7215 / 131980 (5.5%) | −133.8 | −131.7 | 0.23 |
| TCF12 SRX190356 | SK-N-SH Neural | 761 / 13198 (5.8%) | 16424 / 131980 (12.4%) | −133.3 | −131.2 | 0.46 |
| ESR1 SRX330067 | MCF-7 Breast | 238 / 13198 (1.8%) | 8530 / 131980 (6.5%) | −133.3 | −131.1 | 0.28 |
| NR2F2 SRX190293 | MCF-7 Breast | 279 / 13198 (2.1%) | 9227 / 131980 (7.0%) | −133.2 | −131.1 | 0.30 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 996 / 13198 (7.5%) | 3884 / 131980 (2.9%) | −132.9 | −130.8 | 2.56 |
| FOXA1 SRX5323843 | MCF-7 Breast | 122 / 13198 (0.9%) | 6373 / 131980 (4.8%) | −132.9 | −130.8 | 0.19 |
| FOXA2 SRX100448 | Hep G2 Liver | 294 / 13198 (2.2%) | 9453 / 131980 (7.2%) | −132.6 | −130.5 | 0.31 |
| EP300 SRX176885 | MCF-7 Breast | 122 / 13198 (0.9%) | 6362 / 131980 (4.8%) | −132.6 | −130.5 | 0.19 |
| STAT3 SRX2020842 | HCC70 Breast | 494 / 13198 (3.7%) | 12568 / 131980 (9.5%) | −132.3 | −130.2 | 0.39 |
| FOXA2 SRX3230382 | Hep G2 Liver | 369 / 13198 (2.8%) | 10641 / 131980 (8.1%) | −131.9 | −129.7 | 0.35 |
| MECOM SRX23677884 | HNT-34 Blood | 1359 / 13198 (10.3%) | 6284 / 131980 (4.8%) | −131.8 | −129.7 | 2.16 |
| STAT3 SRX150479 | MCF 10A Breast | 242 / 13198 (1.8%) | 8549 / 131980 (6.5%) | −131.8 | −129.7 | 0.28 |
| MECOM SRX23677897 | HNT-34 Blood | 1602 / 13198 (12.1%) | 8003 / 131980 (6.1%) | −131.3 | −129.2 | 2.00 |
| NKX2-1 SRX2164786 | A549 Lung | 454 / 13198 (3.4%) | 11930 / 131980 (9.0%) | −131.2 | −129.1 | 0.38 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 293 / 13198 (2.2%) | 9391 / 131980 (7.1%) | −131.2 | −129.1 | 0.31 |
| FOXA1 SRX1787651 | MCF-7 Breast | 139 / 13198 (1.1%) | 6653 / 131980 (5.0%) | −131.0 | −128.9 | 0.21 |
| Epitope tags DRX443510 | 293 Kidney | 1137 / 13198 (8.6%) | 4819 / 131980 (3.7%) | −130.8 | −128.7 | 2.36 |
| ESR1 SRX20282955 | MCF-7 Breast | 286 / 13198 (2.2%) | 9256 / 131980 (7.0%) | −130.7 | −128.6 | 0.31 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 204 / 13198 (1.5%) | 7847 / 131980 (5.9%) | −130.6 | −128.5 | 0.26 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 349 / 13198 (2.6%) | 10278 / 131980 (7.8%) | −130.5 | −128.4 | 0.34 |
| JUND SRX150408 | HeLa Uterus | 230 / 13198 (1.7%) | 8303 / 131980 (6.3%) | −130.5 | −128.4 | 0.28 |
| Epitope tags SRX10549778 | K-562 Blood | 881 / 13198 (6.7%) | 3226 / 131980 (2.4%) | −130.1 | −128.0 | 2.73 |
| WWTR1 SRX10119378 | MCF 10A Breast | 290 / 13198 (2.2%) | 9295 / 131980 (7.0%) | −129.9 | −127.8 | 0.31 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 255 / 13198 (1.9%) | 8705 / 131980 (6.6%) | −129.6 | −127.5 | 0.29 |
| ESR1 SRX4451213 | MCF-7 Breast | 277 / 13198 (2.1%) | 9074 / 131980 (6.9%) | −129.6 | −127.5 | 0.31 |
| STAT3 SRX150630 | MCF 10A Breast | 244 / 13198 (1.8%) | 8514 / 131980 (6.5%) | −129.6 | −127.5 | 0.29 |
| ESR1 SRX20282946 | MCF-7 Breast | 153 / 13198 (1.2%) | 6877 / 131980 (5.2%) | −129.5 | −127.5 | 0.22 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 189 / 13198 (1.4%) | 7541 / 131980 (5.7%) | −129.4 | −127.3 | 0.25 |
| ESR1 SRX2881000 | MCF-7 Breast | 236 / 13198 (1.8%) | 8372 / 131980 (6.3%) | −129.4 | −127.3 | 0.28 |
| FOXA1 SRX5203303 | MCF-7 Breast | 73 / 13198 (0.6%) | 5232 / 131980 (4.0%) | −129.2 | −127.1 | 0.14 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 158 / 13198 (1.2%) | 6961 / 131980 (5.3%) | −129.1 | −127.0 | 0.23 |
| ESR1 SRX2881002 | MCF-7 Breast | 260 / 13198 (2.0%) | 8763 / 131980 (6.6%) | −128.9 | −126.8 | 0.30 |
| ESR1 SRX2943589 | MCF-7 Breast | 122 / 13198 (0.9%) | 6256 / 131980 (4.7%) | −128.8 | −126.7 | 0.20 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 242 / 13198 (1.8%) | 8453 / 131980 (6.4%) | −128.8 | −126.7 | 0.29 |
| EP300 SRX1012648 | MCF-7 Breast | 114 / 13198 (0.9%) | 6084 / 131980 (4.6%) | −128.6 | −126.5 | 0.19 |
| EP300 SRX2194266 | SUM 159PT Breast | 487 / 13198 (3.7%) | 12327 / 131980 (9.3%) | −128.5 | −126.4 | 0.40 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 201 / 13198 (1.5%) | 7727 / 131980 (5.9%) | −128.4 | −126.3 | 0.26 |
| CDK9 SRX7366783 | MCF-7 Breast | 206 / 13198 (1.6%) | 120 / 131980 (0.1%) | −128.2 | −126.2 | 17.17 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1477 / 13198 (11.2%) | 7186 / 131980 (5.4%) | −128.2 | −126.1 | 2.06 |
| ESR1 SRX10365533 | MCF-7 Breast | 117 / 13198 (0.9%) | 6133 / 131980 (4.6%) | −128.2 | −126.1 | 0.19 |
| HMG20A SRX2630163 | Hep G2 Liver | 138 / 13198 (1.0%) | 6547 / 131980 (5.0%) | −128.0 | −126.0 | 0.21 |
| JUNB SRX10119384 | MCF 10A Breast | 153 / 13198 (1.2%) | 6835 / 131980 (5.2%) | −128.0 | −125.9 | 0.22 |
| FOXA1 SRX1787652 | MCF-7 Breast | 156 / 13198 (1.2%) | 6864 / 131980 (5.2%) | −127.1 | −125.1 | 0.23 |
| FOXA1 SRX3931055 | MCF-7 Breast | 224 / 13198 (1.7%) | 8085 / 131980 (6.1%) | −127.0 | −125.0 | 0.28 |
| FOXA1 SRX100506 | Hep G2 Liver | 367 / 13198 (2.8%) | 10438 / 131980 (7.9%) | −127.0 | −124.9 | 0.35 |
| JUN SRX2355072 | HAEC Cardiovascular | 362 / 13198 (2.7%) | 10360 / 131980 (7.8%) | −127.0 | −124.9 | 0.35 |
| FOS SRX070879 | HUVEC Cardiovascular | 290 / 13198 (2.2%) | 9199 / 131980 (7.0%) | −126.9 | −124.9 | 0.32 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 122 / 13198 (0.9%) | 6195 / 131980 (4.7%) | −126.8 | −124.7 | 0.20 |
| FOSL2 SRX190204 | A549 Lung | 269 / 13198 (2.0%) | 8837 / 131980 (6.7%) | −126.5 | −124.5 | 0.30 |
| PRRX1 SRX15235713 | Hs 578T Breast | 340 / 13198 (2.6%) | 9992 / 131980 (7.6%) | −126.5 | −124.4 | 0.34 |
| NFYB SRX16608147 | HeLa Uterus | 223 / 13198 (1.7%) | 164 / 131980 (0.1%) | −126.5 | −124.4 | 13.60 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 257 / 13198 (1.9%) | 8630 / 131980 (6.5%) | −126.4 | −124.4 | 0.30 |
| FOXA1 SRX190181 | A549 Lung | 183 / 13198 (1.4%) | 7338 / 131980 (5.6%) | −126.4 | −124.3 | 0.25 |
| KMT2A SRX2323891 | 293 Kidney | 774 / 13198 (5.9%) | 2653 / 131980 (2.0%) | −126.4 | −124.3 | 2.92 |
| FOXA1 SRX028635 | MCF-7 Breast | 126 / 13198 (1.0%) | 6260 / 131980 (4.7%) | −126.3 | −124.3 | 0.20 |
| FOXA1 SRX3931043 | MCF-7 Breast | 275 / 13198 (2.1%) | 8924 / 131980 (6.8%) | −126.1 | −124.0 | 0.31 |
| CEBPA SRX2630241 | Hep G2 Liver | 340 / 13198 (2.6%) | 9980 / 131980 (7.6%) | −126.1 | −124.0 | 0.34 |
| FOXA1 SRX1447317 | MCF-7 Breast | 171 / 13198 (1.3%) | 7108 / 131980 (5.4%) | −126.0 | −123.9 | 0.24 |
| ESR1 SRX20282940 | MCF-7 Breast | 311 / 13198 (2.4%) | 9504 / 131980 (7.2%) | −125.8 | −123.7 | 0.33 |
| FOXA1 SRX028634 | MCF-7 Breast | 126 / 13198 (1.0%) | 6243 / 131980 (4.7%) | −125.7 | −123.7 | 0.20 |
| FOXA1 SRX1787655 | MCF-7 Breast | 125 / 13198 (0.9%) | 6221 / 131980 (4.7%) | −125.7 | −123.7 | 0.20 |
| ESR1 SRX8537722 | MCF-7 Breast | 254 / 13198 (1.9%) | 8555 / 131980 (6.5%) | −125.6 | −123.6 | 0.30 |
| ESR1 SRX330070 | MCF-7 Breast | 130 / 13198 (1.0%) | 6320 / 131980 (4.8%) | −125.6 | −123.6 | 0.21 |
| ESR1 SRX1012632 | MCF-7 Breast | 123 / 13198 (0.9%) | 6180 / 131980 (4.7%) | −125.6 | −123.6 | 0.20 |
| ESR1 SRX10365558 | MCF-7 Breast | 184 / 13198 (1.4%) | 7332 / 131980 (5.6%) | −125.6 | −123.5 | 0.25 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 377 / 13198 (2.9%) | 10530 / 131980 (8.0%) | −125.1 | −123.1 | 0.36 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 500 / 13198 (3.8%) | 12390 / 131980 (9.4%) | −125.0 | −123.0 | 0.40 |
| ESR1 SRX3110725 | MCF-7 Breast | 246 / 13198 (1.9%) | 8399 / 131980 (6.4%) | −125.0 | −123.0 | 0.29 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 261 / 13198 (2.0%) | 8652 / 131980 (6.6%) | −125.0 | −123.0 | 0.30 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 644 / 13198 (4.9%) | 1947 / 131980 (1.5%) | −125.0 | −122.9 | 3.31 |
| DAXX SRX1021630 | PC-3 Prostate | 281 / 13198 (2.1%) | 8972 / 131980 (6.8%) | −124.6 | −122.5 | 0.31 |
| EP300 SRX2671813 | Fibroblasts Others | 228 / 13198 (1.7%) | 8077 / 131980 (6.1%) | −124.5 | −122.5 | 0.28 |
| FOS SRX150664 | HUVEC Cardiovascular | 370 / 13198 (2.8%) | 10390 / 131980 (7.9%) | −124.3 | −122.3 | 0.36 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 430 / 13198 (3.3%) | 905 / 131980 (0.7%) | −124.2 | −122.2 | 4.75 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 610 / 13198 (4.6%) | 1777 / 131980 (1.3%) | −124.1 | −122.0 | 3.43 |
| GATA3 SRX5457550 | MCF-7 Breast | 318 / 13198 (2.4%) | 9559 / 131980 (7.2%) | −124.0 | −122.0 | 0.33 |
| NR3C1 SRX10976921 | A549 Lung | 186 / 13198 (1.4%) | 7312 / 131980 (5.5%) | −123.8 | −121.8 | 0.25 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 200 / 13198 (1.5%) | 7561 / 131980 (5.7%) | −123.8 | −121.8 | 0.26 |
| CDK9 SRX7366781 | MCF-7 Breast | 197 / 13198 (1.5%) | 112 / 131980 (0.1%) | −123.7 | −121.7 | 17.59 |
| NR3C1 SRX19024866 | MCF-7 Breast | 81 / 13198 (0.6%) | 5255 / 131980 (4.0%) | −123.7 | −121.7 | 0.15 |
| ESR1 SRX20282953 | MCF-7 Breast | 227 / 13198 (1.7%) | 8016 / 131980 (6.1%) | −123.1 | −121.1 | 0.28 |
| JUN SRX6582172 | Fibroblasts Others | 375 / 13198 (2.8%) | 10412 / 131980 (7.9%) | −122.7 | −120.7 | 0.36 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 279 / 13198 (2.1%) | 8873 / 131980 (6.7%) | −122.6 | −120.6 | 0.31 |
| ESR1 SRX1469949 | MCF-7 Breast | 150 / 13198 (1.1%) | 6617 / 131980 (5.0%) | −122.6 | −120.6 | 0.23 |
| FOXA1 SRX190282 | A549 Lung | 181 / 13198 (1.4%) | 7189 / 131980 (5.4%) | −122.6 | −120.6 | 0.25 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 503 / 13198 (3.8%) | 12339 / 131980 (9.3%) | −122.6 | −120.6 | 0.41 |
| JUND SRX190357 | SK-N-SH Neural | 362 / 13198 (2.7%) | 10196 / 131980 (7.7%) | −122.4 | −120.4 | 0.36 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 241 / 13198 (1.8%) | 8227 / 131980 (6.2%) | −122.3 | −120.3 | 0.29 |
| FOXL2 SRX6957431 | KGN Gonad | 671 / 13198 (5.1%) | 14729 / 131980 (11.2%) | −122.2 | −120.2 | 0.46 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 189 / 13198 (1.4%) | 7316 / 131980 (5.5%) | −122.2 | −120.2 | 0.26 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 235 / 13198 (1.8%) | 8118 / 131980 (6.2%) | −122.1 | −120.1 | 0.29 |
| STAT3 SRX150536 | MCF 10A Breast | 318 / 13198 (2.4%) | 9487 / 131980 (7.2%) | −122.0 | −120.0 | 0.34 |
| ARID1A SRX5089385 | MCF-7 Breast | 202 / 13198 (1.5%) | 7540 / 131980 (5.7%) | −121.9 | −119.9 | 0.27 |
| ESR1 SRX1012629 | MCF-7 Breast | 170 / 13198 (1.3%) | 6964 / 131980 (5.3%) | −121.9 | −119.9 | 0.24 |
| ESR1 SRX330069 | MCF-7 Breast | 166 / 13198 (1.3%) | 6883 / 131980 (5.2%) | −121.7 | −119.7 | 0.24 |
| ESR1 SRX8537723 | MCF-7 Breast | 223 / 13198 (1.7%) | 7894 / 131980 (6.0%) | −121.5 | −119.6 | 0.28 |
| FOXA1 SRX3923517 | MCF-7 Breast | 196 / 13198 (1.5%) | 7419 / 131980 (5.6%) | −121.5 | −119.5 | 0.26 |
| ESR1 SRX1531796 | MCF-7 Breast | 139 / 13198 (1.1%) | 6366 / 131980 (4.8%) | −121.3 | −119.3 | 0.22 |
| RELA SRX5938177 | FaDu Others | 259 / 13198 (2.0%) | 8493 / 131980 (6.4%) | −121.1 | −119.1 | 0.30 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 374 / 13198 (2.8%) | 10328 / 131980 (7.8%) | −120.8 | −118.8 | 0.36 |
| FOXA1 SRX3923518 | MCF-7 Breast | 190 / 13198 (1.4%) | 7286 / 131980 (5.5%) | −120.6 | −118.6 | 0.26 |
| ESR1 SRX20282971 | MCF-7 Breast | 287 / 13198 (2.2%) | 8935 / 131980 (6.8%) | −120.5 | −118.6 | 0.32 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 389 / 13198 (2.9%) | 10552 / 131980 (8.0%) | −120.5 | −118.5 | 0.37 |
| EP300 SRX2194265 | SUM 159PT Breast | 462 / 13198 (3.5%) | 11653 / 131980 (8.8%) | −120.4 | −118.5 | 0.40 |
| SMARCA4 SRX5982340 | A549 Lung | 98 / 13198 (0.7%) | 5527 / 131980 (4.2%) | −120.4 | −118.4 | 0.18 |
| FOXA1 SRX3931054 | MCF-7 Breast | 265 / 13198 (2.0%) | 8567 / 131980 (6.5%) | −120.4 | −118.4 | 0.31 |
| JUN SRX6582171 | GM07492 Others | 567 / 13198 (4.3%) | 13180 / 131980 (10.0%) | −120.3 | −118.3 | 0.43 |
| ZEB1 SRX13298925 | MCF-7 Breast | 168 / 13198 (1.3%) | 6877 / 131980 (5.2%) | −120.2 | −118.2 | 0.24 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 185 / 13198 (1.4%) | 96 / 131980 (0.1%) | −120.0 | −118.0 | 19.27 |
| FOXA1 SRX3923516 | MCF-7 Breast | 201 / 13198 (1.5%) | 7461 / 131980 (5.7%) | −119.9 | −117.9 | 0.27 |
| VGLL1 SRX18013277 | FULVR Breast | 108 / 13198 (0.8%) | 5712 / 131980 (4.3%) | −119.7 | −117.7 | 0.19 |
| RORC SRX5359052 | HCC70 Breast | 998 / 13198 (7.6%) | 4129 / 131980 (3.1%) | −119.6 | −117.7 | 2.42 |
| FOXA1 SRX1161203 | T-47D Breast | 195 / 13198 (1.5%) | 7345 / 131980 (5.6%) | −119.6 | −117.6 | 0.27 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 665 / 13198 (5.0%) | 14536 / 131980 (11.0%) | −119.6 | −117.6 | 0.46 |
| GATA3 SRX6712581 | MCF-7 Breast | 235 / 13198 (1.8%) | 8036 / 131980 (6.1%) | −119.5 | −117.6 | 0.29 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 174 / 13198 (1.3%) | 6966 / 131980 (5.3%) | −119.5 | −117.5 | 0.25 |
| FOXA1 SRX11222438 | MCF-7 Breast | 142 / 13198 (1.1%) | 6366 / 131980 (4.8%) | −119.4 | −117.4 | 0.22 |
| GATAD2A SRX2636506 | Hep G2 Liver | 375 / 13198 (2.8%) | 10290 / 131980 (7.8%) | −119.3 | −117.4 | 0.36 |
| ESR1 SRX3123829 | MCF-7 Breast | 158 / 13198 (1.2%) | 6657 / 131980 (5.0%) | −119.1 | −117.2 | 0.24 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 435 / 13198 (3.3%) | 11190 / 131980 (8.5%) | −118.8 | −116.8 | 0.39 |
| ERG SRX063922 | K-562 Blood | 1188 / 13198 (9.0%) | 5402 / 131980 (4.1%) | −118.6 | −116.6 | 2.20 |
| EP300 SRX1012643 | MCF-7 Breast | 87 / 13198 (0.7%) | 5243 / 131980 (4.0%) | −118.5 | −116.6 | 0.17 |
| EP300 SRX1012644 | MCF-7 Breast | 118 / 13198 (0.9%) | 5877 / 131980 (4.5%) | −118.5 | −116.6 | 0.20 |
| GRHL3 SRX2582162 | NHEK Epidermis | 823 / 13198 (6.2%) | 3060 / 131980 (2.3%) | −118.4 | −116.5 | 2.69 |
| Epitope tags SRX2867680 | 293 Kidney | 1595 / 13198 (12.1%) | 8285 / 131980 (6.3%) | −118.4 | −116.4 | 1.93 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 852 / 13198 (6.5%) | 17033 / 131980 (12.9%) | −118.3 | −116.4 | 0.50 |
| FOXA1 SRX3931033 | MCF-7 Breast | 173 / 13198 (1.3%) | 6905 / 131980 (5.2%) | −118.2 | −116.3 | 0.25 |
| FOXA1 SRX100477 | Hep G2 Liver | 329 / 13198 (2.5%) | 9533 / 131980 (7.2%) | −118.2 | −116.3 | 0.35 |
| PBX3 SRX190343 | SK-N-SH Neural | 616 / 13198 (4.7%) | 13788 / 131980 (10.4%) | −118.0 | −116.1 | 0.45 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 237 / 13198 (1.8%) | 8016 / 131980 (6.1%) | −117.9 | −116.0 | 0.30 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 233 / 13198 (1.8%) | 7948 / 131980 (6.0%) | −117.9 | −115.9 | 0.29 |
| RORC SRX5359053 | HCC70 Breast | 963 / 13198 (7.3%) | 3937 / 131980 (3.0%) | −117.8 | −115.8 | 2.45 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 520 / 13198 (3.9%) | 12403 / 131980 (9.4%) | −117.7 | −115.7 | 0.42 |
| NR3C1 SRX8520802 | HCC1187 Breast | 210 / 13198 (1.6%) | 7539 / 131980 (5.7%) | −117.5 | −115.5 | 0.28 |
| FOXA1 SRX5323829 | T-47D Breast | 151 / 13198 (1.1%) | 6476 / 131980 (4.9%) | −117.4 | −115.5 | 0.23 |
| ARID1A SRX5679787 | 12Z Others | 96 / 13198 (0.7%) | 5396 / 131980 (4.1%) | −117.4 | −115.5 | 0.18 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 573 / 13198 (4.3%) | 1659 / 131980 (1.3%) | −117.4 | −115.4 | 3.45 |
| ESR1 SRX4451212 | MCF-7 Breast | 278 / 13198 (2.1%) | 8679 / 131980 (6.6%) | −117.4 | −115.4 | 0.32 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 299 / 13198 (2.3%) | 9024 / 131980 (6.8%) | −117.3 | −115.4 | 0.33 |
| FOXA1 SRX5203294 | MCF-7 Breast | 69 / 13198 (0.5%) | 4810 / 131980 (3.6%) | −117.2 | −115.2 | 0.14 |
| MethylCap SRX014767 | NB-4 Blood | 1303 / 13198 (9.9%) | 6229 / 131980 (4.7%) | −116.9 | −115.0 | 2.09 |
| ARID1A SRX5089391 | MCF-7 Breast | 151 / 13198 (1.1%) | 6458 / 131980 (4.9%) | −116.8 | −114.9 | 0.23 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 508 / 13198 (3.8%) | 12181 / 131980 (9.2%) | −116.5 | −114.6 | 0.42 |
| AR SRX9109110 | MDA-MB-453 Breast | 565 / 13198 (4.3%) | 13004 / 131980 (9.9%) | −116.5 | −114.6 | 0.43 |
| EP300 SRX100544 | Hep G2 Liver | 216 / 13198 (1.6%) | 7608 / 131980 (5.8%) | −116.3 | −114.4 | 0.28 |
| ARID5B SRX10475139 | Hep G2 Liver | 317 / 13198 (2.4%) | 9265 / 131980 (7.0%) | −116.0 | −114.0 | 0.34 |
| ARID5B SRX3230377 | Hep G2 Liver | 740 / 13198 (5.6%) | 15419 / 131980 (11.7%) | −115.9 | −113.9 | 0.48 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1258 / 13198 (9.5%) | 5943 / 131980 (4.5%) | −115.8 | −113.9 | 2.12 |
| ARID1A SRX5089388 | MCF-7 Breast | 136 / 13198 (1.0%) | 6147 / 131980 (4.7%) | −115.8 | −113.9 | 0.22 |
| ESR1 SRX20282938 | MCF-7 Breast | 237 / 13198 (1.8%) | 7944 / 131980 (6.0%) | −115.8 | −113.8 | 0.30 |
| SOX13 SRX2636248 | Hep G2 Liver | 405 / 13198 (3.1%) | 10620 / 131980 (8.0%) | −115.7 | −113.7 | 0.38 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 442 / 13198 (3.3%) | 1030 / 131980 (0.8%) | −115.5 | −113.6 | 4.29 |
| NR3C1 SRX10977357 | A549 Lung | 175 / 13198 (1.3%) | 6856 / 131980 (5.2%) | −115.5 | −113.5 | 0.26 |
| JUN SRX2355073 | HAEC Cardiovascular | 368 / 13198 (2.8%) | 10046 / 131980 (7.6%) | −115.5 | −113.5 | 0.37 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 200 / 13198 (1.5%) | 7294 / 131980 (5.5%) | −115.3 | −113.4 | 0.27 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 952 / 13198 (7.2%) | 3915 / 131980 (3.0%) | −115.2 | −113.3 | 2.43 |
| ARID1A SRX5089382 | MCF-7 Breast | 202 / 13198 (1.5%) | 7328 / 131980 (5.6%) | −115.2 | −113.3 | 0.28 |
| ESR1 SRX2912055 | MCF-7 Breast | 103 / 13198 (0.8%) | 5479 / 131980 (4.2%) | −115.2 | −113.3 | 0.19 |
| NFIL3 SRX2630334 | Hep G2 Liver | 229 / 13198 (1.7%) | 7787 / 131980 (5.9%) | −115.0 | −113.1 | 0.29 |
| FOXA1 SRX6878603 | LNCAP Prostate | 330 / 13198 (2.5%) | 9434 / 131980 (7.1%) | −115.0 | −113.1 | 0.35 |
| EP300 SRX717859 | HeLa Uterus | 142 / 13198 (1.1%) | 6235 / 131980 (4.7%) | −115.0 | −113.1 | 0.23 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 192 / 13198 (1.5%) | 7144 / 131980 (5.4%) | −115.0 | −113.0 | 0.27 |
| FOXA1 SRX5203307 | MCF-7 Breast | 74 / 13198 (0.6%) | 4861 / 131980 (3.7%) | −114.9 | −113.0 | 0.15 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 260 / 13198 (2.0%) | 8301 / 131980 (6.3%) | −114.9 | −113.0 | 0.31 |
| Epitope tags SRX2745846 | MCF 10A Breast | 192 / 13198 (1.5%) | 7137 / 131980 (5.4%) | −114.8 | −112.9 | 0.27 |
| TLE3 SRX4815194 | SUM 149PT Breast | 223 / 13198 (1.7%) | 7669 / 131980 (5.8%) | −114.5 | −112.6 | 0.29 |
| RNF2 SRX18954719 | SCC-25 Others | 404 / 13198 (3.1%) | 10554 / 131980 (8.0%) | −114.4 | −112.4 | 0.38 |
| NR3C1 SRX10977372 | A549 Lung | 163 / 13198 (1.2%) | 6603 / 131980 (5.0%) | −114.3 | −112.4 | 0.25 |
| SMARCA4 SRX5982341 | A549 Lung | 74 / 13198 (0.6%) | 4844 / 131980 (3.7%) | −114.3 | −112.4 | 0.15 |
| ESR1 SRX330068 | MCF-7 Breast | 132 / 13198 (1.0%) | 6020 / 131980 (4.6%) | −114.2 | −112.3 | 0.22 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 71 / 13198 (0.5%) | 4771 / 131980 (3.6%) | −114.2 | −112.3 | 0.15 |
| PROX1 SRX3230397 | Hep G2 Liver | 213 / 13198 (1.6%) | 7482 / 131980 (5.7%) | −114.0 | −112.1 | 0.28 |
| JUN SRX150358 | HUVEC Cardiovascular | 180 / 13198 (1.4%) | 6897 / 131980 (5.2%) | −113.8 | −111.9 | 0.26 |
| ERG SRX063921 | K-562 Blood | 1119 / 13198 (8.5%) | 5039 / 131980 (3.8%) | −113.8 | −111.9 | 2.22 |
| FOS SRX3322637 | MCF-7 Breast | 155 / 13198 (1.2%) | 6430 / 131980 (4.9%) | −113.5 | −111.6 | 0.24 |
| FOXA1 SRX3923519 | MCF-7 Breast | 177 / 13198 (1.3%) | 6829 / 131980 (5.2%) | −113.4 | −111.5 | 0.26 |
| JADE3 DRX300415 | 293 Kidney | 1142 / 13198 (8.7%) | 5204 / 131980 (3.9%) | −113.2 | −111.3 | 2.19 |
| AR SRX9109113 | MDA-MB-453 Breast | 581 / 13198 (4.4%) | 13102 / 131980 (9.9%) | −113.2 | −111.3 | 0.44 |
| NR3C1 SRX10977373 | A549 Lung | 152 / 13198 (1.2%) | 6360 / 131980 (4.8%) | −113.0 | −111.1 | 0.24 |
| FOXA1 SRX15430999 | T-47D Breast | 330 / 13198 (2.5%) | 9364 / 131980 (7.1%) | −113.0 | −111.1 | 0.35 |
| ESR1 SRX1012633 | MCF-7 Breast | 151 / 13198 (1.1%) | 6330 / 131980 (4.8%) | −112.6 | −110.7 | 0.24 |
| TFAP2C SRX018833 | MCF-7 Breast | 274 / 13198 (2.1%) | 8455 / 131980 (6.4%) | −112.6 | −110.7 | 0.32 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1180 / 13198 (8.9%) | 5482 / 131980 (4.2%) | −112.4 | −110.6 | 2.15 |
| TFAP2C SRX128099 | MCF-7 Breast | 274 / 13198 (2.1%) | 8447 / 131980 (6.4%) | −112.4 | −110.6 | 0.32 |
| TET2 SRX1427029 | 293 Kidney | 980 / 13198 (7.4%) | 4149 / 131980 (3.1%) | −112.4 | −110.5 | 2.36 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 750 / 13198 (5.7%) | 15408 / 131980 (11.7%) | −112.3 | −110.5 | 0.49 |
| ESR1 SRX20282959 | MCF-7 Breast | 116 / 13198 (0.9%) | 5654 / 131980 (4.3%) | −112.3 | −110.4 | 0.21 |
| SSRP1 SRX3436566 | HT-1080 Bone | 254 / 13198 (1.9%) | 304 / 131980 (0.2%) | −112.3 | −110.4 | 8.36 |
| FOXA1 SRX1961158 | T-47D Breast | 290 / 13198 (2.2%) | 8702 / 131980 (6.6%) | −112.2 | −110.4 | 0.33 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 828 / 13198 (6.3%) | 3191 / 131980 (2.4%) | −112.1 | −110.3 | 2.59 |
| FOXA1 SRX1787654 | MCF-7 Breast | 101 / 13198 (0.8%) | 5344 / 131980 (4.0%) | −112.0 | −110.1 | 0.19 |
| ESR1 SRX10365534 | MCF-7 Breast | 77 / 13198 (0.6%) | 4845 / 131980 (3.7%) | −112.0 | −110.1 | 0.16 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 164 / 13198 (1.2%) | 73 / 131980 (0.1%) | −111.8 | −110.0 | 22.47 |
| FOXA1 SRX5323845 | MCF-7 Breast | 100 / 13198 (0.8%) | 5320 / 131980 (4.0%) | −111.8 | −110.0 | 0.19 |
| ESR1 SRX2513520 | MCF-7 Breast | 182 / 13198 (1.4%) | 6861 / 131980 (5.2%) | −111.7 | −109.8 | 0.27 |
| ESR1 SRX5323873 | MCF-7 Breast | 372 / 13198 (2.8%) | 9966 / 131980 (7.6%) | −111.5 | −109.7 | 0.37 |
| EP300 SRX10976625 | A549 Lung | 167 / 13198 (1.3%) | 6587 / 131980 (5.0%) | −111.5 | −109.7 | 0.25 |
| NR3C1 SRX17639413 | A549 Lung | 200 / 13198 (1.5%) | 7172 / 131980 (5.4%) | −111.4 | −109.5 | 0.28 |
| GATAD2A SRX2636507 | Hep G2 Liver | 326 / 13198 (2.5%) | 9242 / 131980 (7.0%) | −111.4 | −109.5 | 0.35 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 431 / 13198 (3.3%) | 10849 / 131980 (8.2%) | −111.3 | −109.4 | 0.40 |
| ESR1 SRX2513517 | MCF-7 Breast | 200 / 13198 (1.5%) | 7166 / 131980 (5.4%) | −111.3 | −109.4 | 0.28 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 324 / 13198 (2.5%) | 9209 / 131980 (7.0%) | −111.2 | −109.4 | 0.35 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 446 / 13198 (3.4%) | 11069 / 131980 (8.4%) | −111.2 | −109.3 | 0.40 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 297 / 13198 (2.3%) | 8774 / 131980 (6.6%) | −111.1 | −109.2 | 0.34 |
| FOXA1 SRX9604647 | LNCAP Prostate | 459 / 13198 (3.5%) | 11254 / 131980 (8.5%) | −111.1 | −109.2 | 0.41 |
| NCOA3 SRX4663589 | MCF-7 Breast | 72 / 13198 (0.5%) | 4706 / 131980 (3.6%) | −111.0 | −109.1 | 0.15 |
| NR3C1 SRX2609664 | HASM2 Lung | 421 / 13198 (3.2%) | 10684 / 131980 (8.1%) | −110.9 | −109.0 | 0.39 |
| FOXA1 SRX1961157 | T-47D Breast | 325 / 13198 (2.5%) | 9209 / 131980 (7.0%) | −110.8 | −109.0 | 0.35 |
| ESR1 SRX1469951 | MCF-7 Breast | 150 / 13198 (1.1%) | 6254 / 131980 (4.7%) | −110.8 | −108.9 | 0.24 |
| AR SRX1067068 | LHSAR Prostate | 359 / 13198 (2.7%) | 9732 / 131980 (7.4%) | −110.7 | −108.8 | 0.37 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 259 / 13198 (2.0%) | 8141 / 131980 (6.2%) | −110.6 | −108.8 | 0.32 |
| GATA3 SRX100559 | T-47D Breast | 332 / 13198 (2.5%) | 9310 / 131980 (7.1%) | −110.6 | −108.7 | 0.36 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 265 / 13198 (2.0%) | 8231 / 131980 (6.2%) | −110.4 | −108.5 | 0.32 |
| FOXA1 SRX219284 | LNCAP Prostate | 414 / 13198 (3.1%) | 10553 / 131980 (8.0%) | −110.2 | −108.4 | 0.39 |
| JUNB SRX10119385 | MCF 10A Breast | 128 / 13198 (1.0%) | 5822 / 131980 (4.4%) | −110.2 | −108.3 | 0.22 |
| ESR1 SRX5323871 | MCF-7 Breast | 333 / 13198 (2.5%) | 9312 / 131980 (7.1%) | −110.2 | −108.3 | 0.36 |
| ZEB1 SRX13298924 | MCF-7 Breast | 139 / 13198 (1.1%) | 6028 / 131980 (4.6%) | −110.1 | −108.3 | 0.23 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 168 / 13198 (1.3%) | 85 / 131980 (0.1%) | −110.0 | −108.1 | 19.76 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 74 / 13198 (0.6%) | 4723 / 131980 (3.6%) | −110.0 | −108.1 | 0.16 |
| ZEB1 SRX13298923 | MCF-7 Breast | 121 / 13198 (0.9%) | 5682 / 131980 (4.3%) | −109.9 | −108.1 | 0.21 |
| FOXA1 SRX5323830 | T-47D Breast | 175 / 13198 (1.3%) | 6681 / 131980 (5.1%) | −109.9 | −108.0 | 0.26 |
| FOXA1 SRX3923515 | MCF-7 Breast | 163 / 13198 (1.2%) | 6463 / 131980 (4.9%) | −109.9 | −108.0 | 0.25 |
| ESR1 SRX2513521 | MCF-7 Breast | 135 / 13198 (1.0%) | 5946 / 131980 (4.5%) | −109.9 | −108.0 | 0.23 |
| FOXA1 SRX3931056 | MCF-7 Breast | 168 / 13198 (1.3%) | 6557 / 131980 (5.0%) | −109.8 | −108.0 | 0.26 |
| CXXC1 SRX1424886 | SEM Blood | 1087 / 13198 (8.2%) | 4907 / 131980 (3.7%) | −109.8 | −108.0 | 2.22 |
| FOXA1 SRX1161205 | T-47D Breast | 153 / 13198 (1.2%) | 6274 / 131980 (4.8%) | −109.6 | −107.8 | 0.24 |
| WWTR1 SRX10119368 | MCF 10A Breast | 213 / 13198 (1.6%) | 7338 / 131980 (5.6%) | −109.6 | −107.7 | 0.29 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 440 / 13198 (3.3%) | 10918 / 131980 (8.3%) | −109.5 | −107.7 | 0.40 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 198 / 13198 (1.5%) | 7075 / 131980 (5.4%) | −109.5 | −107.6 | 0.28 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 165 / 13198 (1.3%) | 6487 / 131980 (4.9%) | −109.4 | −107.6 | 0.25 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 264 / 13198 (2.0%) | 8180 / 131980 (6.2%) | −109.3 | −107.4 | 0.32 |
| PGR SRX3990986 | T-47D Breast | 262 / 13198 (2.0%) | 8143 / 131980 (6.2%) | −109.2 | −107.3 | 0.32 |
| SOX5 SRX2636544 | Hep G2 Liver | 300 / 13198 (2.3%) | 8757 / 131980 (6.6%) | −109.2 | −107.3 | 0.34 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 130 / 13198 (1.0%) | 5830 / 131980 (4.4%) | −109.1 | −107.2 | 0.22 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 464 / 13198 (3.5%) | 11252 / 131980 (8.5%) | −109.0 | −107.2 | 0.41 |
| FOXA1 SRX5323846 | MCF-7 Breast | 108 / 13198 (0.8%) | 5397 / 131980 (4.1%) | −109.0 | −107.2 | 0.20 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 915 / 13198 (6.9%) | 3792 / 131980 (2.9%) | −109.0 | −107.1 | 2.41 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 105 / 13198 (0.8%) | 5336 / 131980 (4.0%) | −108.9 | −107.1 | 0.20 |
| SMARCA4 SRX5982364 | A549 Lung | 86 / 13198 (0.7%) | 4946 / 131980 (3.7%) | −108.9 | −107.0 | 0.17 |
| NR3C1 SRX19024870 | MCF-7 Breast | 92 / 13198 (0.7%) | 5070 / 131980 (3.8%) | −108.8 | −107.0 | 0.18 |
| KAT7 DRX234808 | 293 Kidney | 582 / 13198 (4.4%) | 1809 / 131980 (1.4%) | −108.7 | −106.9 | 3.22 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 90 / 13198 (0.7%) | 5024 / 131980 (3.8%) | −108.6 | −106.8 | 0.18 |
| ARID1A SRX5679788 | 12Z Others | 119 / 13198 (0.9%) | 5601 / 131980 (4.2%) | −108.6 | −106.8 | 0.21 |
| ZFX SRX7805372 | 293 Kidney | 1173 / 13198 (8.9%) | 5519 / 131980 (4.2%) | −108.6 | −106.8 | 2.13 |
| ESR1 SRX5323872 | MCF-7 Breast | 311 / 13198 (2.4%) | 8910 / 131980 (6.8%) | −108.6 | −106.8 | 0.35 |
| CEBPB SRX190345 | MCF-7 Breast | 239 / 13198 (1.8%) | 7739 / 131980 (5.9%) | −108.6 | −106.7 | 0.31 |
| EP300 SRX176883 | MCF-7 Breast | 135 / 13198 (1.0%) | 5907 / 131980 (4.5%) | −108.5 | −106.7 | 0.23 |
| ESR1 SRX1012630 | MCF-7 Breast | 109 / 13198 (0.8%) | 5404 / 131980 (4.1%) | −108.4 | −106.6 | 0.20 |
| ESR1 SRX5323878 | MCF-7 Breast | 308 / 13198 (2.3%) | 8852 / 131980 (6.7%) | −108.3 | −106.5 | 0.35 |
| ESR1 SRX5534831 | MCF-7 Breast | 242 / 13198 (1.8%) | 7780 / 131980 (5.9%) | −108.2 | −106.4 | 0.31 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 578 / 13198 (4.4%) | 12853 / 131980 (9.7%) | −108.2 | −106.3 | 0.45 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 370 / 13198 (2.8%) | 9808 / 131980 (7.4%) | −108.1 | −106.3 | 0.38 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 121 / 13198 (0.9%) | 5621 / 131980 (4.3%) | −108.0 | −106.1 | 0.22 |
| CEBPA SRX4705113 | MOLM-13 Blood | 709 / 13198 (5.4%) | 14657 / 131980 (11.1%) | −107.8 | −106.0 | 0.48 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 197 / 13198 (1.5%) | 6998 / 131980 (5.3%) | −107.7 | −105.8 | 0.28 |
Showing first 500 of 16987 rows.